Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a … [Read more...]
RESEARCH
The Year in Dx VC Investment: Dx/Tools Outperforms Health Care & Liquid Biopsy/AI/ Informatics Outperforms Dx/Tools
February 7, 2018
In a year that witnessed venture capital health care investment reaching an all-time high, diagnostics/tools (Dx/Tools) companies made out particularly well, according to Silicon Valley Banks' … [Read more...]
CAPITAL
Industry Trends: New Report Sheds Light on DX Tech Capital Flows
October 10, 2017
The health care industry has raised $5 billion in venture fund investment in the first half of 2017 and is well on pace to smash the single year record of $7.5 billion set in 2015, according to … [Read more...]
CAPITAL
Grifols Takes 20 percent Stake in Singulex
July 7, 2016
Grifols, the Spanish biotech firm, has taken a 20 percent stake in a California- based laboratory for $50 million. The deal is among the latest involving overseas businesses taking stakes in … [Read more...]
FUNDING
Quanterix Raises $46 Million to Fuel Expansion of Clinical Diagnostics
March 28, 2016
By Stephanie Murg, Managing Director, G2 Intelligence A fresh infusion of capital is set to fuel continued growth at Quanterix Corporation (Lexington, Mass.), which specializes in "high-definition … [Read more...]
AltheaDX Raises $30 Million, Announces New Tests
February 1, 2016
AltheaDX, a California-based lab that focuses on pharmacogenetic testing, has raised $30 million in a third round of financing. The money comes from several investors, including WUXi Healthcare … [Read more...]
Laboratory M&A in 2015: Flat but With Possibilities Moving Forward
February 1, 2016
When it came to mergers and acquisitions in the laboratory arena, 2015 has proven to be pretty much more of the same. Altogether, there were 29 transactions announced during the 2015 calendar year, … [Read more...]
AltheaDX Raises $30 Million, Announces New Tests
January 21, 2016
AltheaDX, a California-based lab that focuses on pharmacogenetic testing, has raised $30 million in a third round of financing. The money comes from several investors, including WUXi Healthcare … [Read more...]
Outlook for Medium-Size Labs Continues to Show Promise
November 19, 2015
The outlook for the mid-size and smaller publicly traded laboratories appears to be bright. Most reported gains in earnings or revenue, or significant capital infusions in the most recent quarter and … [Read more...]
Troubled Calloway Laboratories Shut Its Doors
October 28, 2015
Calloway has gone away. The troubled Calloway Laboratories abruptly shut its doors on Oct. 16. The closure of the Woburn, Mass.-based lab put about 240 employees out of work. Calloway Chief Executive … [Read more...]
